Amit Vohra, PhD, MBA
Promaxo is led by Amit Vohra, PhD, MBA, who is a serial entrepreneur, business strategist, and advisor to several healthcare
Promaxo is led by Amit Vohra, PhD, MBA, who is a serial entrepreneur, business strategist, and advisor to several healthcare
Dinesh Kumar, PhD, MBA, is a medical devices executive and a serial entrepreneur with twenty years of operations and R&D
Aleksandar Nacev, PhD, is an engineering professional with deep expertise in magnetic systems engineering, focused on developing compact magnetic resonance
Srirama Venkataraman, PhD, MBA, leads Promaxo’s clinical development efforts, focusing on research partnerships and advancing MR imaging applications. He brings
Dr. Sethi is the CEO at Golden State Urology and Chief Medical Officer at Promaxo. He is a board certified
Dan McCormick, MBA, is a global commercial executive and general manager with extensive strategy, marketing and sales leadership experience. Leveraging
Alex Gonzalez, General Manager at Promaxo, brings 20+ years in the medical device industry. He has led global business development,
Anil Dhingra, Executive Vice President at Promaxo, is a seasoned healthcare entrepreneur with extensive MedTech expertise. He has led multi
Ram Narayanan, PhD, works as the Sr. VP of Product Development at Promaxo and brings more than a decade of
Matthew Collins, MBA, Promaxo as VP of Global Marketing, brings over 12 years of experience in building global businesses. Leveraging
1 Price, John H., et al. “Accurate Prostate Biopsies Using Low-Field Portable Intervention MRI in an Ambulatory Surgical Center.” IPCU, 2024.
2 Sze, C., et al (2023). “Feasibility and preliminary clinical tolerability of low-field MRI-guided prostate biopsy.” The Prostate, 83(7), 656-662. https://doi.org/10.1002/pros.24499.
3 Sze, C., et al, (2022) “Cost-efficient analysis of a portable low field magnetic resonance imaging system for prostate cancer diagnosis.” Front.
Urol.2:966862. doi: 10.3389/fruro.2022.966862.
4 Chiragzada, S., et al. “Advantageous Detection of Significant Prostate Cancer Using a Low-Field, Office-Based MRI System.” Cureus. 2022 Dec 1;14(12):e32105. doi:10.7759/cureus.32105. PMID:
36601170; PMCID: PMC9805358.
5 Data on file.
6 Xiang, Jianjian, et al. “Transperineal versus transrectal prostate biopsy in the diagnosis of prostate cancer: A systematic review and meta-analysis.ˮ World Journal of Surgical Oncology, vol. 17, no. 1,13 Feb. 2019, https://doi.org/10.1186/s12957-019-1573-0.
*The Promaxo Robot is not yet available for commercial sale.
© 2024 Promaxo, Inc. All rights reserved.